ConsumerInjuryLawyers.com - PRWeb Press Release Group http://www.prweb.com Information for Consumers about dangerous products and drugs. - Powered by PRWeb and RSSPad en xml@emediawire.com xml@emediawire.com 30 Bernstein Liebhard LLP Announces Filing of Denture Cream Lawsuits and Announces Good Morning America's Coverage of Firm's Work For Consumers Poisoned by Zinc in Denture Cream http://www.prweb.com/releases/good-morning-america/denture-cream/prweb2391304.htm New York, New York, May 5, 2009, Bernstein Liebhard LLP announced that last week it filed lawsuits in Pennsylvania state court against GlaxoSmithKline (NYSE: GSK) ("SmithKline"), et al.--the manufacturer of Super Poligrip denture cream--and a lawsuit in federal court against both SmithKline, and Procter & Gamble (NYSE: PG)--the ladder of which is the manufacturer of Fixodent denture cream. The lawsuits (Hickey, et al. v. SmithKline, et al., 1:09-cv-492) allege that these denture creams contain zinc and caused injuries to consumers. The firm further announced that this morning, ABC's Good Morning America ("GMA"), in a nationally televised segment, covered the filing of the lawsuits. The GMA segment profiled one of Bernstein Liebhard's denture cream clients, Ellen Isaacs, and included an interview of Partner Eric Chaffin about the denture cream litigation. (PRWeb May 5, 2009)

Read the full story at http://www.prweb.com/releases/good-morning-america/denture-cream/prweb2391304.htm

]]> Tue, 05 May 2009 07:00:00 GMT http://www.prweb.com/releases/good-morning-america/denture-cream/prweb2391304.htm Bernstein Liebhard LLP Commences Class Action Against Tremont Group and Rye Investments, Alleging Funds Gave Billions to Madoff While Ignoring Red Flags http://www.prweb.com/releases/madoff-ponzi-scheme/tremont-rye-investments/prweb1790464.htm Bernstein Liebhard LLP filed a class action lawsuit on December 23 in the United States District Court for the Southern District of New York against Rye Select Broad Market Fund, LP ("Rye Select"), Rye Investment Management, Tremont Partners, Inc., Tremont Group Holdings, Inc., Robert Schulman, and Jim Mitchell. The suit, filed on behalf of all persons who purchased limited partnership interests in Rye Select from May 10, 1994 through December 22, 2008, alleges that defendants made false and misleading statements regarding their investments with Bernard L. Madoff Investment Securities ("BMIS") and breached their fiduciary duties to the proposed class by failing to conduct appropriate due diligence into the operations of BMIS before entrusting all of Rye Select's capital to be managed by BMIS and its founder, Bernie Madoff. (PRWeb Dec 23, 2008)

Read the full story at http://www.prweb.com/releases/madoff-ponzi-scheme/tremont-rye-investments/prweb1790464.htm

]]> Tue, 23 Dec 2008 08:00:00 GMT http://www.prweb.com/releases/madoff-ponzi-scheme/tremont-rye-investments/prweb1790464.htm Bernstein Liebhard LLP Pursues Madoff Ponzi Scheme Feeder Funds & Hedge Funds http://www.prweb.com/releases/madoff-ponzi-scheme/feeder-hedge-funds/prweb1763054.htm Bernstein Liebhard LLP ("Bernstein Liebhard") announced today that dozens of investors, who have lost hundreds of millions of dollars by investing in Bernard L. Madoff Investment Securities LLC ("Madoff Securities") through hedge funds and other collective investment funds, have consulted and sought the advice of the firm. Bernstein Liebhard is investigating whether, among other things, these investment funds conducted proper due diligence before investing heavily in Madoff Securities, and whether these funds ignored the warning signs that Madoff was conducting a large-scale fraud. Bernstein Liebhard is also investigating whether these funds misrepresented to investors the concentration of the funds' investments in Madoff Securities. (PRWeb Dec 16, 2008)

Read the full story at http://www.prweb.com/releases/madoff-ponzi-scheme/feeder-hedge-funds/prweb1763054.htm

]]> Tue, 16 Dec 2008 08:00:00 GMT http://www.prweb.com/releases/madoff-ponzi-scheme/feeder-hedge-funds/prweb1763054.htm Bernstein Liebhard & Lifshitz, LLP Announces Final Approval of Lumenis Securities Class Action Settlement http://www.prweb.com/releases/BernsteinLiebhard/ConsumerInjuryLawyers/prweb1454924.htm On August 25, 2008, Judge Deborah A. Batts of the U.S. District Court for the Southern District of New York gave final approval to a $20.1 million securities class action settlement with Lumenis Ltd. and certain individual defendants in In re Lumenis Securities Litigation, No. 02-CV-1989 (S.D.N.Y.). The lead plaintiffs, represented by co-lead counsel Bernstein Liebhard & Lifshitz, LLP, had alleged that defendants engaged in improper revenue recognition. (PRWeb Oct 12, 2008)

Read the full story at http://www.prweb.com/releases/BernsteinLiebhard/ConsumerInjuryLawyers/prweb1454924.htm

]]> Sun, 12 Oct 2008 07:00:00 GMT http://www.prweb.com/releases/BernsteinLiebhard/ConsumerInjuryLawyers/prweb1454924.htm Bernstein Liebhard & Lifshitz, LLP Announces Final Approval of Royal Dutch Shell Securities Class Action Settlement http://www.prweb.com/releases/BernsteinLiebhard/RoyalDutchShellSettlement/prweb1441394.htm On September 26, 2008, Judge Joel A. Pisano gave final approval to a U.S. settlement with a minimum cash value of $130 million in In re Royal Dutch/Shell Transport Securities Litigation (D.N.J.) (the "Action"). This settlement is in addition to a $350 million European settlement on behalf of a class of non-U.S. purchasers of Shell securities on non-U.S. exchanges (the "Non-U.S. Purchasers"), which the court-appointed lead plaintiffs and Bernstein Liebhard & Lifshitz, LLP were, in the words of Judge Pisano, a "substantial factor" in bringing about. (PRWeb Oct 10, 2008)

Read the full story at http://www.prweb.com/releases/BernsteinLiebhard/RoyalDutchShellSettlement/prweb1441394.htm

]]> Fri, 10 Oct 2008 07:00:00 GMT http://www.prweb.com/releases/BernsteinLiebhard/RoyalDutchShellSettlement/prweb1441394.htm Bernstein Liebhard & Lifshitz, LLP Named to National Law Journal's Plaintiffs' Hot List for Sixth Straight Year http://www.prweb.com/releases/Bernstein-liebhard/mel-lifshitz/prweb1439634.htm The National Law Journal has named Bernstein Liebhard & Lifshitz, LLP to its Plaintiffs' Hot List for sixth straight year. The firm was recognized for its work representing plaintiffs in securities litigation, as well as consumer, antitrust and mass tort litigation. (PRWeb Oct 9, 2008)

Read the full story at http://www.prweb.com/releases/Bernstein-liebhard/mel-lifshitz/prweb1439634.htm

]]> Thu, 09 Oct 2008 07:00:00 GMT http://www.prweb.com/releases/Bernstein-liebhard/mel-lifshitz/prweb1439634.htm Three Bernstein Liebhard & Lifshitz Partners Named Super Lawyers http://www.prweb.com/releases/BernsteinLiebhard/SuperLawyers/prweb1424314.htm New York Super Lawyers magazine has named three partners at Bernstein Liebhard & Lifshitz, LLP ("Bernstein Liebhard") as being among the top lawyers in New York State for 2008: Stanley D. Bernstein, Jeffrey M. Haber, and Rebecca Katz. Mr. Bernstein was also named a Super Lawyer in 2007. (PRWeb Oct 5, 2008)

Read the full story at http://www.prweb.com/releases/BernsteinLiebhard/SuperLawyers/prweb1424314.htm

]]> Sun, 05 Oct 2008 07:00:00 GMT http://www.prweb.com/releases/BernsteinLiebhard/SuperLawyers/prweb1424314.htm Information About Trasylol (Aprotinin) Being Linked to Tens of Thousands of Deaths http://www.prweb.com/releases/Trasylol/lawyers/prweb1407314.htm The FDA ordered Bayer to remove Trasylol (aprotinin) from the market after studies linked Trasylol to tens of thousands of deaths. A study looked at more than 78,000 patients from January 2003 to January 2006 and concluded that Trasylol users have a 64% higher death risk than those that took an alternative drug. The increased death risk was due to Trasylol dangerous side effects including kidney failure, heart attack, and stroke. ConsumerInjuryLawyers.com provides detailed information, helpful links and the CBS 60 Minutes Video Segment about Trasylol. (PRWeb Oct 2, 2008)

Read the full story at http://www.prweb.com/releases/Trasylol/lawyers/prweb1407314.htm

]]> Thu, 02 Oct 2008 07:00:00 GMT http://www.prweb.com/releases/Trasylol/lawyers/prweb1407314.htm Information About the Drug Spiriva Being Linked to Increased Risk of Strokes, Heart Attacks and Cardiovascular Deaths http://www.prweb.com/releases/2008/09/prweb1391174.htm A new JAMA article reports on a study allegedly showing that the blockbuster drug Spiriva HandiHaler may cause higher incidents of heart attacks, strokes and cardiovacsular deaths than a placebo population. The FDA issued an early warning communication in March 2008 identifying similar dangers. The drug companies that distribute Spiriva dispute the findings. The issue is likely to be hotly debated in the coming months. (PRWeb Sep 29, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1391174.htm

]]> Mon, 29 Sep 2008 07:00:00 GMT http://www.prweb.com/releases/2008/09/prweb1391174.htm